Nrf2 activation by neferine mitigates microglial neuroinflammation after subarachnoid hemorrhage through inhibiting TAK1-NF-κB signaling.

• Neferine reduced subarachnoid hemorrhage (SAH)-induced oxidative stress and neuroinflammation. • Neferine enhanced the nuclear factor E2-related factor 2 (Nrf2)-antioxidant response element (ARE) signaling and suppressed transforming growth factor beta-activated kinase 1(TAK1)-NF-κB signaling. • Neferine inhibited M1 microglial polarization and promoted M2 microglial transformation. • ML385 suppressed Nrf2-ARE signaling and further induced TAK1-NF-κB activation after SAH. • ML385 promoted M1 microglial polarization and abated the neuroprotective effects of NE against SAH. • LPS aggravated TAK1-NF-κB activation and reversed the beneficial effects of NE after SAH. Oxidative stress and neuroinflammation are two major causes leading to early brain injury after subarachnoid hemorrhage (SAH). Nuclear factor E2-related factor 2 (Nrf2) is a critical transcription factor that contributes to antioxidant responses. Additionally, Nrf2 could inhibit transforming growth factor beta-activated kinase 1 (TAK1), which plays a vital role in microglial activation-mediated neuroinflammation. Neferine (NE) exhibits considerable protective effects in diverse disease models. However, the detailed effect and mechanism of NE on SAH remain unknown. Our data showed that NE treatment significantly reduced behavior and cognitive impairment, and brain edema in the early period after SAH. In addition, NE mitigated SAH-induced oxidative damage, neuroinflammation, and neural death. Moreover, NE inhibited M1 microglial polarization and enhanced M2 phenotype microglia both in vivo and in vitro. Further investigations revealed that NE enhanced the Nrf2-antioxidant response element (ARE) signaling pathway and suppressed TAK1-NF-κB signaling. In contrast, depletion of Nrf2 by ML385 suppressed Nrf2-ARE signaling, induced TAK1-NF-κB activation, and further promoted M1 microglial polarization. Additionally, ML385 abated the neuroprotective effects of NE against SAH. Notably, LPS also aggravated TAK1-NF-κB activation and reversed the beneficial effects of NE after SAH. In summary, NE provides protection after SAH by inhibiting oxidative stress and modulating microglial polarization through Nrf2 activation and TAK1-NF-κB suppression. [ABSTRACT FROM AUTHOR]